Regional alterations in rat brain neurotransmitter systems following chronic lithium treatment.
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002531:Cerebellum / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000031:analogs & derivatives / Q000378:metabolism; D006624:Hippocampus / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D007700:Kinetics; D008094:Lithium / Q000494:pharmacology*; D008297:Male; D018377:Neurotransmitter Agents / Q000378:metabolism*; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects / Q000378:metabolism; D011985:Receptors, Serotonin / Q000378:metabolism; D012413:Rubidium / Q000494:pharmacology
D018377:Neurotransmitter Agents; D011955:Receptors, Drug; D011985:Receptors, Serotonin; D008094:Lithium; C001746:3-methoxytyramine; D012413:Rubidium; D004298:Dopamine